A certificate of analysis is the only document connecting a vial to a batch, and knowing which fields carry real information separates a useful document from a marketing sheet.
Key Takeaways
- A defensible certificate carries the batch or lot number, the sequence including any modifications, the molecular weight, the purity value with the method, and the identity result.
- Check that an identity result exists at all and that it states observed versus theoretical mass.
- Missing batch numbers, purity quoted without a method, no chromatogram, and stock photographs of certificates are all warning signs.
Fields that must be present
A defensible certificate carries the batch or lot number, the sequence including any modifications, the molecular weight, the purity value with the method, and the identity result. Absence of a batch number makes the document untraceable and effectively worthless.
Method detail is the tell
Purity without a stated column, gradient, and detection wavelength cannot be reproduced or compared. Suppliers that publish the chromatogram and the method parameters are providing evidence; suppliers publishing only a number are providing a claim.
For related mechanism work, see peptide circular dichroism.
Identity versus purity again
Check that an identity result exists at all and that it states observed versus theoretical mass. A certificate showing purity but no mass-spectrometric confirmation has not established that the right molecule was made.
Salt form and net content
Look for the counterion and, ideally, net peptide content. Without these you cannot convert weighed mass into molar quantity, and any quantitative conclusion carries an unknown systematic error.
Red flags worth acting on
Missing batch numbers, purity quoted without a method, no chromatogram, and stock photographs of certificates are all warning signs. Where material feeds into quantitative work, request the raw data rather than a summary.
Experimental Conditions and Practical Setup
A certificate is assessed by checking that every stated value is traceable to a method: the purity figure to a stated column, gradient, and wavelength; identity to an observed-versus-theoretical mass; and quantity to a net content determination. Where any of these links is missing, the document is a claim rather than a measurement.
Certificate fields and what each one proves
| Field | If present | If absent |
|---|---|---|
| Batch or lot number | Result is traceable to material | Document is unusable for disputes |
| Observed versus theoretical mass | Identity confirmed | Purity may describe the wrong molecule |
| Purity with method parameters | Result reproducible | Figure cannot be compared |
| Counterion stated | Molar quantity derivable | Systematic error in dosing |
Practical Notes for the Bench
- Reject any certificate without a traceable batch number.
- Require stated column, gradient, and wavelength alongside purity.
- Confirm an observed-versus-theoretical mass is reported for identity.
Frequently Asked Questions
What is the single most important field?
The batch number, because without it nothing on the certificate can be traced back to the material in the vial.
Is a purity percentage enough?
No. Without the method parameters and a chromatogram the number cannot be verified or compared between suppliers.
Should I ask for raw data?
Yes for any quantitative work; request the chromatogram and mass spectrum rather than a summary sheet.
Should I accept a certificate that reports purity but no mass?
No. Without an identity result the supplier has not established that the correct molecule was made, and a pure but wrong peptide is a common failure mode.
Related Reading
- peptide circular dichroism
- peptide mass spectrometry identification
- peptide solubility testing
- reconstituting lyophilised peptides
- Selank and Semax research
References & Further Reading
- Han Z et al. Weizmannia coagulans BC99 alleviates pediatric allergic rhinitis via the gut microbiota-SCFAs- immunomodulatory axis: A randomized, double-blind, placebo-controlled trial. Int Immunopharmacol. 2026. PubMed 41197269
- Todd CA et al. Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL). J Immunol Methods. 2014. PubMed 24120573
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- USP general chapters on pharmaceutical analysis
Educational content for research staff. Nothing here should be read as advice on human or veterinary use of any compound.
Reviewed by James Okoro, BSc, Laboratory Operations & Documentation.